Morphogenesis of the hepatitis B virus by Patient, R, Hourioux, C, Roingeard, P

Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles. by Chapel, C, Garcia, C, Roingeard, P, Zitzmann, N, Dubuisson, J, Dwek, R, Trépo, C, Zoulim, F, Durantel, D

Targeting of MuLV Gag to the plasma membrane is mediated by PI(4,5)P₂and PhosphatidylSerine by Summers Michael F, Roy C, Roingeard P, Saad JS, Juilliard F, Hamard-Peron E, Darlix JL, Picart C, Muriaux D

Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles by Chapel, C, Garcia, C, Bartosch, B, Roingeard, P, Zitzmann, N, Cosset, F, Dubuisson, J, Dwek, R, Trepo, C, Zoulim, F, Durantel, D

Alpha-glucosidase inhibitors prevent the assembly and induce a reduction of HCV infectivity by Chapel, C, Garcia, C, Bartosch, B, Roingeard, P, Zitzmann, N, Cosset, F, Dubuisson, J, Dwek, R, Trepo, C, Zoulim, F, Durantel, D

Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. by Chapel, C, Garcia, C, Bartosch, B, Roingeard, P, Zitzmann, N, Cosset, F, Dubuisson, J, Dwek, R, Trépo, C, Zoulim, F, Durantel, D